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dynamic structural changes which facilitate substrate release. Although
receptor-G Protein interactions are well known a lack of understanding of
non-receptor-G protein interactions still exists, namely Ga interactions with
the non-receptor GEF Ric-8A. A 10-to-100 fold decrease in nucleotide ex-
change rate for Ric-8A compared to receptors has been shown, which begs
the question: What is the cause for the decrease between receptor and non-
receptor GEF activity? To answer this, the dynamic and structural interactions
of Ga-Ric-8A have been probed by fluorescence anisotropy and single-
molecule Fo¨rster Resonance Energy Transfer (smFRET). Conformational
changes in the ms times-scale of inter and intra-domain states and increase
segmental motions of the switch (I-III) regions seem to play a role in substrate
release.
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The epidermal growth factor receptor (EGFR) is a member of the ErbB family
of receptor tyrosine kinases which play an important role in a number of phys-
iological responses and have also been identified as a common signaling
component in several cancer types. Physiological signaling is initiated by
ligand binding which stabilizes EGFR dimers, resulting in auto-
phosphorylation of the intracellular kinase domain. Mutation of EGFR is asso-
ciated with tumor progression due to constitutive activity resulting from several
known kinase domain variants. Our previous work has shown that ligand-
induced dimerization of wild type EGFR results in decreased receptor mobility,
and that this reduction in mobility is dependent on kinase activity. Therefore,
we wondered whether ligand-independent activity of EGFR mutants correlates
with differences in receptor mobility or dimerization kinetics.
Here, we employ multi-color, single particle tracking (SPT) of quantum dots to
visualize and quantify the dynamics and interactions of individual receptors
within the membrane. Using a novel, high-speed hyperspectral microscope,
we are able to track up to eight spectrally distinct quantum dots for visualiza-
tion and quantification of receptor interactions. From this data, we quantify re-
ceptor dimerization kinetics using a Hidden Markov Model. We find that
unliganded EGFR mutants exhibit a reduced mobility and longer dimer life-
times when compared to wild type. These results are consistent with constitu-
tive activity of the EGFR mutants and suggest that the active kinase domain
facilitates dimer formation in the absence of ligand. Moreover, we test the ef-
fects of clinical tyrosine kinase inhibitors on the single molecule behavior of
EGFR mutants. We further examined the mobility and clustering of EGFR
within the cellular actin cytoskeleton by hyperspectral tracking over GFP-
actin, as well as two-color super-resolution microscopy.
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BACKGROUND AND PURPOSE. Insulin stimulates the transport of glucose
in target tissues by triggering the translocation of glucose transporter 4 (GLUT4)
to the plasma membrane. Resistance to insulin, the major abnormality in type 2
diabetes, results in a decreased GLUT4 translocation efficiency, leading to hy-
perglycemia. Thus, special attention is drawn on the search for compounds,
termed insulin mimetics, which are able to enhance this translocation process
in the absence of insulin.
EXPERIMENTAL APPROACH. In the present work Total Internal Reflection
Fluorescence (TIRF) microcopy was applied to quantify GLUT4 translocation
in highly insulin sensitive CHO-K1 cells expressing a GLUT4-myc-GFP fusion
protein. Customized software was developed to further increase the throughput
capability.
KEYRESULTS.Using our approachwe proved theGLUT4 translocation inhib-
itory properties of selected substances in live and fixed cells. In addition,we vali-
dated the efficacy of known GLUT4 translocation inducers and characterized
newsubstances,mainly phytochemicals,with potential insulinmimetic function.CONCLUSIONS AND IMPLICATIONS. Taken together, TIRF microscopy
proved to be a superior tool for the quantification of GLUT4 translocation
and the search for insulin mimetic drugs.
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The human cannabinoid receptor, CB1, a G protein-coupled receptor (GPCR),
contains a somewhat long (~110 a.a.) amino terminus. We explored a potential
role for the CB1 N-terminus in modulating ligand binding to the receptor.
Although the majority of the CB1 N-terminus is not necessary for high-
affinity ligand binding, previous studies have found that mutations introduced
into a conserved membrane proximal region (MPR) do impair the receptors
ability to bind ligand. Moreover, the highly conserved MPR (~ residues 90-
110) contains two invariant cysteine residues that are conserved in all CB1 re-
ceptors. Our data suggest these two cysteines (C98 and C107) form a disulfide
in human CB1, and this C98-C107 disulfide is more accessible to reducing
agents than the disulfide in extracellular loop 2 (EL2). The presence of the
N-terminal C98-C107 disulfide appears to modulate ligand binding to the re-
ceptor in a way that can be quantitatively analyzed by an allosteric model.
The C98-C107 disulfide also alters the effects of CB1 allosteric ligands, Org
27569 and PSNCBAM-1. Our results provide new insights to how the N-termi-
nal MPR and EL2 act together to influence the high-affinity orthosteric ligand
binding site in CB1, and suggest the CB1 N-terminal MPR may be an area
through which allosteric modulators can act.
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The active metarhodopsin II (MII) conformation of rhodopsin loses activity
when it releases its agonist, all-trans retinal, and decays to the inactive apopro-
tein, opsin. Here, we studied how the conformational change and retinal release
are linked. In our experiments, we used tryptophan induced quenching of fluo-
rescence (TrIQ) to observe movement of transmembrane helix 6 (TM6) through
an attached fluorescent probe, while simultaneously measuring intrinsic trypto-
phan fluorescence to monitor retinal release. The data show TM6 moves from
its position in the active structure back into the helical bundle in opsin (indic-
ative of the inactive conformation) with a rate matching that of retinal exit; both
processes exhibit a t1/2 of ~15 minutes at 20C in 0.05% dodecyl maltoside at
pH 6.0. We further tested the correlation of these events in two ways. First, we
carried out an Arrhenius analysis and determined near identical activation en-
ergies for TM6 resetting and retinal release (~23 kcal/mol). Additionally, we
tested the effect of altering the rate of retinal release on the rate of the confor-
mational change. The release process was slowed by introducing a mutation to
the Schiff base counterion, E113Q. When retinal exit was slowed, the rate of
TM6 resetting decelerated to the same degree. Likewise, accelerating retinal
release by using hydroxylamine to hydrolyze the Schiff base linkage caused
a corresponding acceleration of the rate of TM6 movements. With these tools
in hand, we have begun investigating the dynamics and energetic of other
movements in the protein, with the goal of constructing a more comprehensive
model for receptor deactivation following light-activation, as well as testing
how mutations (such as retinitis pigmentosa), small molecules, and other pro-
teins can effect these events.
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With almost 1000 unique G Protein Coupled Receptors (GPCR’s) mapped in
the human genome, and an estimated 40% of current marketed drugs targeting
these proteins, there is little question that it worthwhile to develop newmethods
to more efficiently screen for small molecule agonists and antagonists. One
such group of GPCRs, the endothelin receptors, is home to one of the most
potent vasoconstrictors, the Endothelin A receptor (ETA) which is an excellent
target for selective antagonists for the treatment of pulmonary arterial hyperten-
sion. We have developed a method for screening selective antagonists which
target intracellular domains of ETA and ETB using a soluble template (to
mimic a region of the transmembrane domains of ETA and ETB) fused to
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generated a structural model of the ETA Carboxyl terminus (Residues 373-
427) from NMR data both in solution and in the presence of DPC micelles.
We hope that with these tools we can soon identify and develop targeted inhib-
itors of vasoconstriction through high throughput screening and rational design.
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Receptor mediated signaling is often precisely regulated in both space and time,
which necessitates the application of methods for simultaneously capturing
both aspects with a high level of detail. The epidermal growth factor receptor
(EGFR) is a prominent example as numerous, dynamic interactions exist be-
tween this receptor and its downstream effectors. To advance spatiotemporal
insights on EGFR signaling, we have developed a technique by which litho-
graphic processes and chemical modification are used to pattern micron-sized
features of EGF on silicon or glass. Fluorescently labeled streptavidin, cova-
lently attached to these surfaces, binds biotinylated EGF for the presentation
of immobilized receptor ligand. NIH-3T3 cells stably over-expressing EGFR
are allowed to settle on these surfaces and are subsequently fixed. Fluorescence
microscopy is then used to visualize specific cellular proteins concentrating at
patterned EGF features and correlation coefficient analysis measures the extent
of colocalization. We have observed and quantified the recruitment of various
EGFR signaling components, including Ras, MEK, and phosphorylated Erk in
an F-actin and phosphoinositide synthesis-dependent manner. Further, we find
that paxillin-GFP becomes visibly clustered at patterned EGF features. Pre-
treatment of cells with the EGFR inhibitor Iressa significantly reduces this pax-
illin clustering behavior and establishes the dependence of paxillin on tyrosine
kinase activation. These studies reveal the formation of multi-protein EGFR
signaling complexes in response to spatially defined growth factor. To measure
dynamics of EGFR protein redistributions in living cells, we have recently
extended this patterning technique to coverslip-thick glass substrates and
two-color total internal reflection fluorescence microscopy (TIRFM). This is
providing for the real time investigation of signaling proteins and their recruit-
ment to patterned EGF. We are also applying alternative analysis methods for
quantifying the redistribution of cellular components to take full advantage of
this patterned ligand approach.
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Abstract: The thrombopoietin receptor (TpoR/c-MPL) plays an important role
in megakaryocyte differentiation, platelet formation and hematopoietic stem
cell renewal. Its intracellular membrane-proximal region, which constitutively
binds to JAK2, regulates activation of the receptor and signalling of the JAK-
STAT pathway. However, the activation mechanism of TpoR at the molecular
level is not understood. In our report, cell proliferation assay, fluorescence, cir-
cular dichroism and NMR spectroscopy are employed to elucidate the role of
the juxtamembrane (JM) region in TpoR activation. We find that secondary
structure and membrane affinity of the JM region are strongly controlled by
W515 at the hinge region between the transmembrane and JM regions. Second-
ary structure prediction also reveals that the JM region in TpoR has a larger he-
lical content than in other single-chained cytokine receptors. Thus, we
hypothesize that TpoR, which is regulated by a more structured JM region, is
strictly inactive when unliganded and can perform ligand-specific signalling.
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Fibroblast growth factor receptor 3 (FGFR3) is a receptor tyrosine kinase which
resides in the plasma membrane and regulates cell survival, differentiation and
angiogenesis. Fibroblast growth factors (fgfs) are a family of secreted protein
ligands which bind to FGFRs to potentiate signaling. FGFR3 functions via
lateral dimerization in the cellular plasma membrane. It has been shown that
FGFR3 forms dimers in the absence of fgf ligands, however it is not clear
how fgfs affect FGFR3 dimerization. Previously we have developed a quanti-
tative imaging FRET (QI-FRET) technique to study membrane protein interac-tions in a cell-derived model system. Here we have used this method to measure
thermodynamics of FGFR3 interactions in the presence of fgf1 and fgf2 in Chi-
nese Hamster Ovary (CHO) cell derived vesicles. These measurements provide
novel mechanistic insights into the role of ligand binding in receptor tyrosine
kinase interactions.
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G-protein coupled receptors (GPCRs) comprise the largest protein family and
mediate the vast majority of signal transduction processes in the body. Until
recently GPCRs were not considered to be voltage dependent. Newly it was
shown for several GPCRs that the first step in GPCR activation, the binding
of agonist to the receptor, is voltage sensitive: Voltage shifts the receptor be-
tween two states that differ in their binding affinity. Here we show that this shift
involves the rate constant of dissociation. We used the m2 muscarinic receptor
(m2R) a prototypical GPCR and measured directly the dissociation of [3H]ACh
from m2R expressed Xenopus oocytes. We show, for the first time, that the
voltage dependent change in affinity is implemented by voltage shifting the re-
ceptor between two states that differ in their rate constant of dissociation.
Furthermore, we provide evidence that suggest that the above shift is achieved
by voltage regulating the coupling of the GPCR to its G protein.
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Atypical antipsychotic drugs targeting the Gq-coupled 5-HT2A receptor (2AR)
are widely used in the treatment of schizophrenia and psychosis. Recent studies
point to a new class of potential antipsychotic drugs targeting the Gi-coupled
metabotropic glutamate 2 receptor (mGluR2). We recently reported that a het-
eromeric complex formed between these two GPCRs integrates the actions of
serotonergic and glutamatergic drugs, modulating the balance between Gi and
Gq signaling and allowing us to predict the psychoactive properties of these
drugs (Fribourg et al. 2011, Cell. 147(5):1011-23). Our results uncover a uni-
fying mechanism of action of two families of antipsychotic drugs and pave
the road for the development of assays for high-throughput screening of sero-
tonergic and glutamatergic drugs. While developing such an assay, we needed
to address a controversy raised by a recent study, in which co-expression of the
two receptors in HEK-293 cells had no significant effect on either Gi or Gq
signaling in response to several serotonergic and glutamatergic drugs (Delille
et al., 2012, Neuropharmacology 62(7):2184-91). Since in Xenopus oocytes
the degree of functional crosstalk between the two receptors depended on their
expression levels, we generated several clones of HEK-293 cells expressing
different levels of the two receptors in the background of the G-protein
inwardly rectifying GIRK1/GIRK4 channel, which can serve as a reporter
for both Gi and Gq signaling. Using fluorescence indicator and electrophysio-
logical assays we were able to identify clones showing various degrees of func-
tional crosstalk between the two receptors in response to single ligands. Our
results have confirmed functional crosstalk of the two receptors. Even in cases
where a single ligand failed to show crosstalk, like in the Delille et al. study, a
combination of ligands targeting both receptors could elicit functional
crosstalk.
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Oligomerization of transmembrane proteins is emerging as an important
concept in cellular function(1). In the G-protein coupled receptor (GPCR) field
oligomerization remains to be fully explored. The majority of assays available
for measuring GPCR oligomerization are cell based and rely on ensemble read-
outs(2,3). As a complement to such assays we suggest to quantitatively study
the oligomerization of receptors reconstituted in single synthetic liposomes
(proteoliposomes). A liposome model membrane system provides a simplified
